Glucocorticoid-targeting of the adenylyl cyclase signaling pathway in the cerebellum of young vs. aged rats

Brain Research

Volumn 800, Issue 2, 1998, Pages 236-244

  Slotkin, Theodore A ^a   Zhang, Jian ^a   McCook, Everett C ^a   Seidler, Frederic J ^a  

^a Dept Pharmacol Cancer Biol D ^*  (United States)

Author keywords

Adrenergic receptor; Adenylyl cyclase; Aging; Cerebellum; Dexamethasone; Glucocorticoid

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; DEXAMETHASONE; FLUORIDE; FORSKOLIN; GLUCOCORTICOID; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATE; ISOPRENALINE; MANGANESE;

ADOLESCENT; AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CEREBELLUM; CONTROLLED STUDY; ENZYME ACTIVITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ADRENERGIC BETA-AGONISTS; AGING; ANIMALS; ANTI-INFLAMMATORY AGENTS; CEREBELLUM; DEXAMETHASONE; FLUORIDES; FORSKOLIN; GLUCOCORTICOIDS; GTP-BINDING PROTEINS; GUANOSINE TRIPHOSPHATE; ISOPROTERENOL; KIDNEY; MALE; MANGANESE; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 0032479969     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00518-6     Document Type: Article

References (48)

1. G.K. Aghajanian, D.S. Charney, R.S. Duman, G.R. Heninger, Neurobiology of Affective Disorders, Raven Press, New York, 1993.
2. Araki T., Kato H., Fujiwara T., Itoyama Y. Age-related changes in bindings of second messengers in the rat brain. Brain Res. 704:1995;227-232.
3. Birmingham M.K., Sar M., Stumpf W.E. Dexamethasone target sites in the central nervous system and their potential relevance to mental illness. Cell. Mol. Neurobiol. 13:1993;373-386.
4. Brodaty H., Peters K., Boyce P., Hickie I., Parker G., Mitchell P., Wilhelm K. Age and depression. J. Affect. Disord. 23:1991;137-149.
5. Carroll B.J., Curtis G.C., Mendels J. Cerebrospinal fluid and plasma free cortisol concentrations in depression. Psychol. Med. 6:1976;235-244.
6. Carroll B.J., Heath B., Jarrett D.B. Corticosteroids in brain tissue. Endocrinology. 97:1975;290-300.
7. Chan M.Y., Lee P.H.K. Serotonin uptake and imipramine binding in rat platelets after chronic dexamethasone and amitriptyline treatment. Pharmacol. Res. Commun. 17:1985;619-632.
8. Davies A.O., Lefkowitz R.J. Regulation of β-adrenergic receptors by steroid hormones. Ann. Rev. Physiol. 46:1984;119-130.
9. Fumagalli F., Jones S.R., Caron M.G., Seidler F.J., Slotkin T.A. Expression of mRNA coding for the serotonin transporter in aged vs. young rat brain: differential effects of glucocorticoids. Brain Res. 719:1996;225-228.
10. Fuxe K., Cintra A., Chadi G., Gustafsson J.Å., Agnati L.F. Central glucocorticoid receptors and neuronal plasticity. Methods Neurosci. 22:1994;372-382.
11. Gould T.J., Bickford P.C. The effects of aging on cerebellar β-adrenergic receptor activation and motor learning in female F344 rats. Neurosci. Lett. 216:1996;53-56.
12. Gould T.J., Bickford P.C. Age-related deficits in the cerebellar beta adrenergic signal transduction cascade in Fischer 344 rats. J. Pharmacol. Exp. Ther. 281:1997;965-971.
13. Greenberg L.H., Weiss B. β-Adrenergic receptors in aged rat brain: reduced number and capacity of pineal gland to develop supersensitivity. Science. 201:1978;61-63.
14. Hassan A.H.S., von Rosenstiel P., Patchev V.K., Holsboer F., Almeida O.F.X. Exacerbation of apoptosis in the dentate gyrus of the aged rat by dexamethasone and the protective role of corticosterone. Exp. Neurol. 140:1996;43-52.
15. Heinsimer J.A., Lefkowitz R.J. The impact of aging on adrenergic receptor function: clinical and biochemical aspects. J. Am. Geriatr. Soc. 33:1985;184-188.
16. Jesberger J.A., Richardson J.S. Animal models of depression: parallels and correlates to severe depression in humans. Biol. Psychiatry. 20:1985;764-784.
17. Kin N.M.K.N.Y., Nair N.P.V., Amin M., Schwartz G., Ahmed S.K., Holm P., Katona C., Kragh-Sorensen P., Klitgaard N., Song W.Y., West T.E.G., Stage K. The dexamethasone suppression test and treatment outcome in elderly depressed patients participating in a placebo-controlled multicenter trial involving moclobemide and nortriptyline. Biol. Psychiatry. 42:1997;925-931.
18. Leung F.C.L., Saggerson E.D., Clark J.B. Hypothyroidism alters the effect of GTP on adenylyl cyclase in forebrain and hindbrain synaptosomal membranes from 15-day-old rats. Int. J. Dev. Neurosci. 14:1996;701-705.
19. Makman M.H., Ahn H.S., Thal L.J., Sharpless N.S., Dvorkin B., Horowitz S.G., Rosenfeld M. Evidence for selective loss of brain dopamine- and histamine-stimulated adenylate cyclase activities in rabbits with aging. Brain Res. 192:1980;177-183.
20. Masoro E.J. Glucocorticoids and aging. Aging Clin. Exp. Res. 7:1995;407-413.
21. McEwen B.S. Re-examination of the glucocorticoid hypothesis of stress and aging. Prog. Brain Res. 93:1992;365-380.
22. Meaney M.J., O'Donnell D., Rowe W., Tannenbaum B., Steverman A., Walker M., Nair N.P.V., Lupien S. Individual differences in hypothalamic-pituitary-adrenal activity in later life and hippocampal aging. Exp. Gerontol. 30:1995;229-251.
23. Meister B., Johnson H., Ulfhake B. Increased expression of serotonin transporter messenger RNA in raphe neurons of the aged rat. Mol. Brain Res. 33:1995;87-96.
24. Minneman K.P., Pittman R.N., Molinoff P.B. β-Adrenergic receptor subtypes: properties, distribution, and regulation. Ann. Rev. Neurosci. 4:1981;419-461.
25. Mobley P.L., Sulser F. Adrenal corticoids regulate sensitivity of noradrenaline receptor-coupled adenylate cyclase in brain. Nature. 286:1980;608-609.
26. Narayanan N., Derby J.A. Alterations in the properties of β-adrenergic receptors of myocardial membranes in aging: impairments in agonist-receptor interactions and guanine nucleotide regulation accompany diminished catecholamine-responsiveness of adenylate cyclase. Mech. Ageing Dev. 19:1982;127-139.
27. Oxenkrug G.F., McIntyre I.M., Stanley M., Gershon S. Dexamethasone suppression test: experimental model in rats and effect of age. Biol. Psychiatry. 19:1984;413-416.
28. Peng M.T., Lee L.R. Regional differences of neuron loss of rat brain in old age. Gerontology. 25:1979;205-211.
29. 2-adrenergic receptor density in the cerebellum of aging rats. J. Neurochem. 35:1980;273-275.
30. Ritchie J.C., Scotch R.L., Nemeroff C.B., Carroll B.J. The effect of age on DST status and plasma dexamethasone concentration in depressed patients. Biol. Psychiatry. 27:1990;45A-46A.
31. i in ROS 17/2.8 cells. Endocrinology. 118:1986;2510-2518.
32. Sapolsky R.M. The physiological relevance of glucocorticoid endangerment of the hippocampus. Ann. NY Acad. Sci. 746:1994;294-304.
33. Scarpace P.J., Turner N., Mader S.L. β-Adrenergic function in aging: basic mechanisms and clinical implications. Drugs Aging. 1:1991;116-129.
34. Schmahmann J.D., Pandya D.N. The cerebrocerebellar system. Int. Rev. Neurobiol. 41:1997;31-60.
35. Sharma R.P., Pandey G.N., Janicak P.G., Peterson J., Comaty J.E., Davis J.M. The effect of diagnosis and age on the DST: a meta-analytic approach. Biol. Psychiatry. 24:1988;555-568.
36. Shen T.S., Suzuki Y., Poyard M., Miyamoto N., Defer N., Hanoune J. Expression of adenylyl cyclase mRNAs in the adult, in developing, and in the Brattleboro rat kidney. Am. J. Physiol. Cell Physiol. 42:1997;C323-C330.
37. Slotkin T.A., Hays J.C., Nemeroff C.B., Carroll B.J. Dexamethasone Suppression Test identifies a subset of elderly depressed patients with reduced platelet serotonin transport and resistance to imipramine inhibition of transport. Depression Anxiety. 6:1997;19-25.
38. Slotkin T.A., McCook E.C., Ritchie J.C., Carroll B.J., Seidler F.J. Serotonin transporter expression in rat brain regions and blood platelets: aging and glucocorticoid effects. Biol. Psychiatry. 41:1997;172-183.
39. Slotkin T.A., McCook E.C., Ritchie J.C., Seidler F.J. Do glucocorticoids contribute to the abnormalities in serotonin transporter expression and function seen in depression? An animal model. Biol. Psychiatry. 40:1996;576-684.
40. Slotkin T.A., Thai L., McCook E.C., Saleh J.L., Zhang J., Seidler F.J. Aging and glucocorticoids: effects on cell signaling mediated through adenylyl cyclase. J. Pharmacol. Exp. Ther. 279:1996;478-491.
41. Slotkin T.A., Whitmore W.L., Barnes G.A., Krishnan K.R.R., Blazer D.G., Knight D.L., Nemeroff C.B. Reduced inhibitory effect of imipramine on radiolabeled serotonin uptake into platelets in geriatric depression. Biol. Psychiatry. 25:1989;687-691.
42. Stangl D., Pfohl B., Zimmerman M., Coryell W., Corenthal C. The relationship between age and post-dexamethasone cortisol: a test of three hypotheses. J. Affect. Disord. 11:1986;185-197.
43. Stein-Behrens B.A., Sapolsky R.M. Stress, glucocorticoids, and aging. Aging. 4:1992;197-210.
44. Stiles M.L., Allen L.V., Prince S.J., Holland J.S. Stability of dexamethasone sodium phosphate, diphenhydramine hydrochloride, lorazepam, and metoclopramide hydrochloride in portable infusion-pump reservoirs. Am. J. Hosp. Pharm. 51:1994;514-517.
45. Vernadakis A., Kentroti S. Glial cells derived from aged mouse brain in culture display both mature and immature astrocytic phenotypes. J. Neurosci. Res. 38:1994;451-458.
46. White M., Roden R., Minobe W., Khan M.F., Larrabee P., Wollmering M., Port J.D., Anderson F., Campbell D., Feldman A.M., Bristow M.R. Age-related changes in β-adrenergic neuroeffector systems in the human heart. Circulation. 90:1994;1225-1238.
47. Wilkinson C.W., Peskind E.R., Raskind M.A. Decreased hypothalamic-pituitary-adrenal axis sensitivity to cortisol feedback inhibition in human aging. Neuroendocrinology. 65:1997;79-90.
48. Young A.H. Glucocorticoids, serotonin and mood. Br. J. Psychiatry. 165:1994;271-272.